Lymphangiogenesis and tumor metastasis: More questions than answers

Lymphology

Volumn 33, Issue 4, 2000, Pages 144-147

  Pepper, M S ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; GLYCOSAMINOGLYCAN; HYALURONIC ACID; MUCOPROTEIN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ANGIOGENESIS; EDITORIAL; ENDOTHELIUM; HOMEOBOX; HUMAN; LYMPH FLOW; LYMPHATIC DRAINAGE; METASTASIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TUMOR CELL;

ANGIOGENESIS INHIBITORS; ENDOTHELIAL GROWTH FACTORS; HUMANS; LYMPHATIC METASTASIS; LYMPHOKINES; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034500050     PISSN: 00247766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (34)

1. Extracellular compartments of solid tumors
2. Experimental studies on the spread of cancer in the lymphatic system. II: Absence of a lymphatic supply in carcinoma
3. Experimental studies on lymphatic vascular changes in the development of cancer
4. Absence of functional lymphatics within a murine sarcoma: A molecular and functional evaluation
5. Attenuated cells in breast stroma: The missing lymphatic system of the breast
6. Molecular biology of cancer: Invasion and metastasis
7. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases
8. Vascular endothelial growth factor-related protein: A ligand and specific activator of the tyrosine kinase receptor Flt4
9. Current biology of VEGF-B and VEGF-C
10. Regulation of angiogenesis via vascular endothelial growth factor receptors
11. Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium
12. Prox1 function is required for the development of the murine lymphatic system
13. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan
14. Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical-pathologic features
15. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis
16. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer
17. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues
18. Expression of vascular endothelial growth factors A, B, C, and D and their relationships to lymph node status in lung adenocarcinoma
19. Increased vascular endothelial growth factor and vascular endothelial growth factor-c and decreased nm23 expression associated with microdissemination in the lymph nodes in stage I non-small cell lung cancer
20. VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
21. Cystic hygroma reconsidered: Hamartoma or neoplasm? Primary culture of an endothelial cell line from a massive cervicomediastinal hygroma with bony lymphangiomatosis
22. Lymphatic endothelial and smooth-muscle cells in tissue culture
23. Tumor-promoting phorbol esters induce angiogenesis in vitro
24. In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells
25. Vascular endothelial growth factor (VEGF)-C synergises with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro, and alters endothelial cell proteolytic properties
26. The regulatory effects of cytokines on lymphatic angiogenesis
27. Production of plasminogen activator and plasminogen activator inhibitor by bovine lymphatic endothelial cells: Modulation by TNF-α
28. Reaction of experimentally isolated lymphatic capillaries in the tails of amphibian larvae
29. Observations on the new growth of lymphatic vessels as seen in transparent chambers introduced into the rabbit" ear
30. Genes expressed in human tumor endothelium
31. Manipulating angiogenesis: From basic science to the bedside
32. Chemotherapy targeted to tumor vasculature
33. Antioangiogenic gene therapy
34. New developments in angiogenesis: A major mechanism for tumor growth and target for therapy